Mount Sinai Unveils New Sleep Research
Researchers will present studies at SLEEP 2024, covering CPAP withdrawal effects, hypoxic burden in OSA treatment, and new diagnostic tools.
Source: sleepreviewmag.com
Excessive Daytime News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Excessive Daytime. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Excessive Daytime Today - Breaking & Trending Today
Axsome to Present New Sunosi Data at SLEEP 2023
Axsome Therapeutics Inc will present new data on Sunosi (solriamfetol) at SLEEP 2023, including results from the SHARP study.
Source: sleepreviewmag.com
Axsome Therapeutics, Inc.: Axsome Therapeutics Enters into License Agreement with Pharmanovia to Expand Commercialization and Further Develop Sunosi® (solriamfetol) in Europe
Axsome to receive an upfront payment of $66 million, and is eligible to receive sales-based and other milestones totaling up to $101 million Pharmanovia is responsible for all ongoing and future clinical
Source: finanznachrichten.de
Axsome Therapeutics Hosts Sunosi® Investor Update Virtual
NEW YORK, June 28, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel...
Source: globenewswire.com
Axsome Therapeutics Completes U.S. Acquisition of Sunosi® (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
Axsome is committed to providing patients uninterrupted access to Sunosi and advancing research for patients living with sleep disorders Insurance coverage for...
Source: prnewswire.com